Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze KROS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate KROS investment potential.

What is KROS stock price today?

Get real-time KROS stock price, historical data, and price charts on Financhill. Track KROS performance with our advanced analysis tools.

Is KROS a good investment?

Evaluate KROS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy KROS stock?

To buy KROS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of KROS?

View detailed market capitalization data and company valuation metrics for KROS on our comprehensive analysis page.

What is the P/E ratio of KROS?

Use our fundamental analysis tools to view KROS P/E ratio and compare valuation metrics with industry peers.

What are KROS earnings?

View KROS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Keros Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

KROS
Keros Therapeutics, Inc.

Last Price:

$16.56

Seasonality Move:

-4.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Keros Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Keros Therapeutics, Inc. has on average historically fallen by 4.5% based on the past 5 years of stock performance.
Keros Therapeutics, Inc. has fallen lower in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Is Keros Therapeutics, Inc. Stock Undervalued?

The current Keros Therapeutics, Inc. [KROS] share price is $16.61. The Score for KROS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Keros Therapeutics, Inc. has on average historically fallen by 4.5% based on the past 5 years of stock performance.

Keros Therapeutics, Inc. Stock Rating

Sell

Keros Therapeutics, Inc. (KROS) is a Sell

Is Keros Therapeutics, Inc. overpriced?

Keros Therapeutics, Inc. has fallen lower in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Keros Therapeutics, Inc. Stock Price History

Is KROS stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

kerostx.com

52-Week Data

52-Week High:

22.55

52-Week Low:

9.12

Prediction Charts

Market Cap:

506M

Price in USD:

16.61

Volume:

209.7K

Beta:

1.13

Technical Analysis

SMA50:

19.33

SMA100:

17.65

SMA200:

16.02

52-Wk Change:

62.84%

Stock Predictions

Is Keros Therapeutics, Inc. stock public?

Yes, Keros Therapeutics, Inc. is a publicly traded company.
What is the Keros Therapeutics, Inc. stock quote today?

The Keros Therapeutics, Inc. stock price is 16.61 USD today.
How to buy Keros Therapeutics, Inc. stock online?

You can buy Keros Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-26	19.04	18.77	19.11	18.65
Jan-27	18.75	18.30	19.13	18.22
Jan-28	18.16	17.83	18.35	17.80
Jan-29	17.83	17.99	18.19	17.81
Jan-30	18.27	17.91	18.27	17.65
Feb-2	17.91	18.40	18.74	17.80
Feb-3	18.37	18.47	18.74	18.03
Feb-4	18.46	18.05	18.46	17.71
Feb-5	17.89	17.24	18.16	17.22
Feb-6	17.45	17.57	17.90	17.35
Feb-9	17.49	17.53	17.61	17.21
Feb-10	17.44	17.15	17.59	17.08
Feb-11	17.02	17.04	17.08	16.31
Feb-12	17.16	16.61	17.17	16.55

Keros Therapeutics, Inc. Earnings

Keros Therapeutics, Inc. Earnings Report: Per Share Keros Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics, Inc. Forecast Revenue Growth

Keros Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.81 per share, and a decrease next year of $0.79 per share.

* Keros Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.